Yaoyigu blockchain
1.002657 Zhongke Jincai
2.300663 Kelan software
3.002152 radio and television express
4.300079 digital technology
5.300542 Xinchen technology
6.600570 Hengsheng electronics
< P > 7.300561 Huijin technology8.002063 high beam software
9.603106 Hengyin finance
blockchain concept stocks may become the leading stocks as follows:
1. Blockchain concept stock 1: easy to see stock (600093. SH) concept stock index
the company's main supply chain management has been actively transforming in recent years. On the one hand, the company strives to improve the business scale of supply chain management and commercial factoring
on the other hand, with the transformation of financial technology as the center and the application of blockchain technology in supply chain finance as the breakthrough, the whole policy has made every effort to promote the development of the "easy to see block" system. In the first half of 2017, the development of the "easy to see block" System 1.0 has been successfully completed, and it has been commercialized in the fields of medicine and large commodities
2. Blockchain concept stock 2: gawaita
is a leading financial information manufacturer in China. Relying on its own advantages in bank IT solutions and bank customer resources, gawaita provides bank it system cloud services
3, blockchain concept stock 3: Xinchen technology is mainly engaged in application software development business, software and hardware system integration business and professional technical service business. In recent years, Xinchen technology has made bold attempts in innovation. The company has made some progress in the application of new technologies such as cloud computing, big data, artificial intelligence and blockchain in the financial instry
the domestic L / C business system based on blockchain technology has been successfully launched in banks, and is expected to graally become a new growth point of the company's software solution business
the leading stock index is the stock that has influence and appeal on other stocks in the same instry ring the stock market speculation in a certain period, and its rise and fall often play a guiding and exemplary role in the rise and fall of other stocks in the same instry
leading stock is not unchangeable, its status can only be maintained for a period of time. The basis of becoming a leading stock is that any information related to a stock will be immediately reflected in the stock price
conditions for leading stocks:
1. Leading stocks must start from the trading board, which is the most accurate attack signal for both sides. Indivial stocks that can't be trading can't be leading stocks.
2. Leading stocks are the best low price stocks, and low price stocks are sought after by many investors, because high price stocks are difficult to speculate
3. The circulation market of leading stocks should be moderate, suitable for large capital operation and retail investors chasing up and down, and large market value stocks and small cap stocks can not be the leader
4. Leading stocks meet the daily KDJ, weekly KDJ and monthly KDJ at the same time
5. Leading stocks usually rise against the market limit at the end of market decline when the market panics, or start ahead of the market, and undergo a round of market decline test
the leading stock index is the stock that has influence and appeal on other stocks in the same instry ring the stock market speculation in a certain period, and its rise and fall often play a guiding and exemplary role in the rise and fall of other stocks in the same instry. Leading stock is not immutable, its status can only be maintained for a period of time
< H2 > reference: network leading stocksHengbao stock: big data security analysis
Radio and television express: digital currency, blockchain research
Westone: distributed encryption
WINTIME: blockchain technology reserve, But out of the initial stage
gaoweida: application of blockchain bills
Changliang Technology: it service provider of distributed core system of Weizhong bank
Tianji Technology: distributed storage
Wanxiang Qianchao: large shareholder Wanxiang Group establishes blockchain laboratory
Xinya Da: following the application of blockchain and other technologies in the financial instry
Yuanying China: a digital currency crowdfunding company This is the first time.
Blockchain is a new application mode of distributed data storage, which is an important concept of bitcoin. At present, there are 35 stocks associated with the blockchain concept in the A-share market, of which 6 blockchain concept listed companies are traded on the Shanghai Stock Exchange, and 29 blockchain concept listed companies are traded on the Shenzhen Stock Exchange
according to the correlation of blockchain, the leading stocks of blockchain concept stocks are most likely to be born from Xinchen technology, luyitong and Sifang Jingchuang
Xinchen Technology: on September 29, 2016, the company said in the interaction that the company is now doing research and development of blockchain technology
Lu Yitong: the company plans to raise 67.9691 million shares of additional shares of RMB 24.57 per share, and the total amount of supporting funds will not exceed RMB 1.670 billion, which will be used to pay the cash consideration of this transaction, construct the block chain ASIC chip instrialization project, artificial intelligence ASIC chip R & D center, chip proct marketing and service network, etc
Sifang Jingchuang: on May 31, 2016, the inaugural meeting and the first general meeting of the financial blockchain cooperation alliance (Shenzhen) was officially held in Shenzhen Wuzhou Hotel, and the company was one of the members of the meeting
The concept theme of blockchain involves a lot of indivial stocks
it is recommended to log in the stock software and query according to the concept theme to see all indivial stocks
the screenshots of some listed companies with the highest growth rate on the closing day before the lunar new year are as follows
Recently, blockchain is the most eye-catching one that appears frequently in major media
three , blockchain data is completely open and transparent. If anti anonymous identification technology can be developed in the future and a user's information can be seen through password cracking, the positioning and identification of some key targets may also pose a threat to data security and personal privacy
At present, supervision is still on the way. Decentralization means that the main body is not clear, which also brings great difficulty to supervision; In particular, regulators under the blockchain technology will face the "huge amount" of data, and it is difficult to achieve accurate supervision by standardizing the transparency of information. In addition, the vacancy and lag of regulatory legal system make the use of blockchain lack of necessary institutional norms and legal protection, and increase the market riskobviously, blockchain technology is not a "safe box" to ensure the absolute security of financial instry and other economic activities, nor a "panacea" to serve all economic activities . Both the enterprises involved in the research and development and application of blockchain technology and the investors involved in the investment of instrial projects in blockchain should maintain a cautious and rational attitude
Hangzhou YaoYuan blockchain Technology Co., Ltd. is another limited liability company incorporated on July 20, 2018, with its registered address at room 1105, 11th floor, No. 1, Yinhu innovation center, No. 9, Fuxian Road, Yinhu street, Fuyang District, Hangzhou City, Zhejiang Province
the unified social credit code / registration number of Hangzhou YaoYuan blockchain Technology Co., Ltd. is 91330183ma2cd8362t, and the enterprise legal person is Yang xuesun. At present, the enterprise is in the status of cancellation
the business scope of Hangzhou YaoYuan blockchain Technology Co., Ltd. is: blockchain, computer software and hardware technology research and development, technical services; Computer system integration; Computer hardware and software and auxiliary equipment, decorative materials (except paint), electronic procts, communication equipment sales; Computer network engineering construction; Advertising design, proction, agency and release (except online advertising); Planting of Chinese medicinal materials, trees and flowers; Agricultural procts display; Ecological agriculture tourism; Food processing; Agricultural technology consultation Projects that need to be approved according to law can be operated only after being approved by relevant departments)
check more information of Hangzhou YaoYuan blockchain Technology Co., Ltd. through aiqicha
Domestic leading generic stocks: Hengrui pharmaceutical, Huadong pharmaceutical, Huahai pharmaceutical, Puli pharmaceutical, Jingxin pharmaceutical, xinlitai
Jiangsu Hengrui Pharmaceutical Co., Ltd., approved by Jiangsu Provincial People's government, is a joint-stock company jointly established by Lianyungang Hengrui Group Co., Ltd. and other five sponsors in April 1997. It is the largest research and proction base of anti-tumor drugs in China Hangzhou Huadong Pharmaceutical Group Co., Ltd., formerly known as Zhejiang Pharmaceutical Factory, was founded in 1952 and later renamed Hangzhou No.2 pharmaceutical factory and Hangzhou Huadong pharmaceutical factory On December 16, 1992, Hangzhou Huadong Pharmaceutical Group Co., Ltd. was established on the basis of Hangzhou Huadong pharmaceutical factory, which has developed into a joint-stock enterprise - Huadong Pharmaceutical Co., Ltd., and four Sino foreign joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Hangzhou moshadong Pharmaceutical Co., Ltd., Hangzhou Jiuyuan genetic engineering Co., Ltd Zhejiang Huayi Pharmaceutical Co., Ltd Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989, formerly known as Linhai xunqiao synthetic chemical plant, and was established as Zhejiang Huahai Pharmaceutical Co., Ltd. in January 2001. In March 2003, the company's shares were successfully listed on Shanghai Stock Exchange. Stock abbreviation: Huahai pharmaceutical, stock code: 600521 Hainan Puli Pharmaceutical Co., Ltd., founded in 1992, is a high-tech enterprise specializing in the R & D, proction and sales of chemical pharmaceutical preparations, and has passed the certification of international leading enterprise of pharmaceutical preparations of Chinese pharmaceutical enterprises. The company has two wholly-owned subsidiaries, Zhejiang Puli Pharmaceutical Co., Ltd. and Hangzhou Saili Pharmaceutical Research Institute Zhejiang Jingxin Pharmaceutical Co., Ltd., founded in 1974, has developed into a national key high-tech enterprise and one of the top 100 pharmaceutical enterprises in China. In July 2004, it was successfully listed in Shenzhen Stock Exchange6. Shenzhen xinlitai Pharmaceutical Co., Ltd. was approved by the Ministry of Commerce of the people's Republic of China on the reply of the Ministry of Commerce on approving Shenzhen xinlitai Pharmaceutical Co., Ltd. to be restructured into a Sino foreign joint stock enterprise (SZP [2007] No. 1016), and obtained the approval certificate of the people's Republic of China for enterprises invested by overseas Chinese from Taiwan, Hong Kong and Macao issued by the Ministry of Commerce, Shenzhen xinlitai Pharmaceutical Co., Ltd. (hereinafter referred to as & quot; Shenzhen xinlitai & quot;) A foreign-invested joint-stock limited company wholly changed and established in accordance with the law has a registered capital of 85 million yuan and obtained the business license of enterprise legal person with the registration number of 440301501124347
policies and regulations
on April 3, 2018, the general office of the State Council issued the opinions on reforming and improving the supply guarantee and use policy of generic drugs (hereinafter referred to as the opinions), pointing out that we should promote the supply side structural reform of the pharmaceutical instry and improve the drug supply guarantee ability around the outstanding problems faced by the generic drug instry, In order to rece the drug cost burden of the whole society, ensure the drug demand of the broad masses of the people, and speed up the leap from a big pharmaceutical country to a powerful pharmaceutical country in China, the specific work suggestions were put forward from three aspects of promoting the research and development of generic drugs, improving the quality and efficacy of generic drugs, and improving the support policies